These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 17617419

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells.
    Jang YY, Cho D, Kim SK, Shin DJ, Park MH, Lee JJ, Shin MG, Shin JH, Suh SP, Ryang DW.
    Ann Clin Lab Sci; 2012; 42(1):42-9. PubMed ID: 22371909
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production.
    Derby EG, Reddy V, Nelson EL, Kopp WC, Baseler MW, Dawson JR, Malyguine AM.
    Cytokine; 2001 Jan 21; 13(2):85-90. PubMed ID: 11145847
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis.
    Kantor TV, Whiteside TL, Friberg D, Buckingham RB, Medsger TA.
    Arthritis Rheum; 1992 Jun 21; 35(6):694-9. PubMed ID: 1376124
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Flow cytometric assay for the simultaneous analysis of cell-mediated cytotoxicity and effector cell phenotype.
    Derby E, Reddy V, Baseler M, Malyguine A.
    Biotechniques; 2001 Sep 21; 31(3):660, 664-5. PubMed ID: 11570508
    [No Abstract] [Full Text] [Related]

  • 17. Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognition.
    Mueller EA, Anderer FA.
    Cancer Res; 1990 Jun 15; 50(12):3646-51. PubMed ID: 1692765
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells.
    Ozdemir O, Ravindranath Y, Savaşan S.
    J Immunother; 2005 Jun 15; 28(1):44-52. PubMed ID: 15614044
    [Abstract] [Full Text] [Related]

  • 19. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
    Dannemann BR, Morris VA, Araujo FG, Remington JS.
    J Immunol; 1989 Oct 15; 143(8):2684-91. PubMed ID: 2477453
    [Abstract] [Full Text] [Related]

  • 20. Single-colour flow cytometric assay to determine NK cell-mediated cytotoxicity and viability against non-adherent human tumor cells.
    Thakur A, Zaman A, Hummel J, Jones K, Hortelano G.
    Biotechnol Lett; 2012 Mar 15; 34(3):447-53. PubMed ID: 22187077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.